• Metadoro
  • Products
  • News and analysis

News and analysis

Check market insights shared by our community members
14.01.2025
Tezos Is Seen Hodling above $1.200

Tezos (XTZ) has declined slightly by 0.2% this week, trading at $1.249, following Bitcoin’s (BTC) drop to $89,158, which triggered widespread altcoin sell-offs due to concerns of a potential further decline in BTC to $80,000. However, Bitcoin managed to hold above the critical support level at $89,000-$91,000, offering some relief to the broader crypto market.

Speculation about a shift in U.S. trade policy has provided additional support to crypto assets. Reports suggest the new U.S. administration may pursue a gradual increase in tariffs rather than an abrupt hike, which could help alleviate inflationary pressures and lead to a less aggressive monetary stance from the Federal Reserve.

This development is a positive signal for the cryptocurrency market and may help Tezos maintain its position above the key support level of $1.200.

10.01.2025
Dollar Strength Is a Given

The very first slice of statistical data on business activity from the United States this year reaffirmed an almost clear irrelevance and even potential hurtfulness of any immediate steps towards further lowering interest rates on U.S. Dollar-nominated loans from a purely economic point of view. The ISM Manufacturing PMI (Purchasing Managers Index), based on polls compiled from executives in over 400 industrial companies in late December, came out at 49.3 points vs 48.4 a month ago and 48.2 in average analyst estimates. This showed that a slowdown was occurring at a slower or even insignificant pace, keeping inflation risks on the table, especially when the price component increased from 50.3 to 52.5 with a similar rate of increase in new orders. Meanwhile, non-manufacturing PMI came out at 54.1 on Tuesday, compared to 53.5 in analyst polls and 52.1 a month ago, with a contribution of business activity components even jumped to a surprising 58.2 against declining from 57.2 in November to only 53.7 in December.

In other words, the economy is not cooling, and is rather in a positive acceleration, which in turn may lead to a recovery in wage rises and therefore to higher demand pressure, which may be reflected soon in higher producer purchase and output prices. Doubts of the major U.S. financial regulator are understandable at this point after its triple rate cut from 5.5% to 4.5% in 2024. The Federal Reserve (Fed) will now pay closer attention not only to consumer inflation measures, but also to producer prices (PPI), which is just going to be released on coming Tuesday, January 14. And so, this will become the next reference point in the further U.S. Dollar’s trajectory. The Greenback index (DX) is picking up steam since reaching a new record high for the last two years at 109.35, with its temporary pullbacks being limited by a 107.50 support area that previously served as a strong multi-month technical resistance.

In this context, the British Pound (GBPUSD) updated its lows since November 2023 to touch 1.2237 on January 9, EURUSD feels quite comfortable within a range between 1.02 and 1.0450, which corresponds to its 2-year bottom, and having a bias towards a possible further decline. The Aussie (AUDUSD) is one-step away from taking the path for a breakthrough to a quite unknown territory of its 5-year lows that were last time recorded when the initial outbreak of the Covid-19 happened.

A varying extent of the American Dollar strength is surely data dependent as the market community is eagerly waiting for the U.S. job data later today. The average expectations on new Nonfarm Payrolls is just a bit above 150,000 vs 227,000 in early December 2024 and nearly 160,000 for the previous four months on average. However, any value close to 150,000, plus or minus 20,000, or any higher number, may be considered as another positive sign for the Greenback, following the ADP national employment report which contained only 122,000 on Wednesday. The oppressive nature of average hourly wage in its dynamics, +0.4% each time from September to December, also matters.

The protective quality of investing more funds into the U.S. Dollar and U.S. bonds against tariff threats is switched on anyway, based on more than a 95% chance for the Fed to keep rates on pause at its January 29 meeting, according to CME's FedWatch tool. Federal Reserve officials never go against a well-established market consensus, when it is almost unanimous, for not to rock the boat of relative market trend stability. The central bankers' reluctance to shift the Fed fund rates lower before mid-March, if not early May, continues to play in favour of short-term speculative transactions on the foreign exchange market, bearing in mind all the listed currency instruments. Some intraday volatility may take place, especially in the case of appearing an abnormal two-digit non-farm value, but not a change in overall direction.

09.01.2025
VeChain Is Suffering on Rising Borrowing Costs

VeChain (VET) has fallen 12.7% this week, trading at $0.0445, underperforming the broader cryptocurrency market. Bitcoin (BTC), the leading cryptocurrency, has declined by 5.6% to $93,220, with bearish momentum building as it approaches key support at $89,000-$91,000. This decline is largely attributed to tightening monetary conditions in the United States, which continue to weigh on risk assets. Investor confidence is further shaken by significant net outflows from spot BTC-ETFs, which lost $583 million on Wednesday, marking the second-largest single-day outflow on record.

If BTC falls below the critical support level of $89,000-$91,000, VeChain is likely to extend its losses, with prices potentially declining another 10% to $0.0400. A sustained drop in BTC could push VET even lower, towards $0.0300. Conversely, a strong rebound in BTC prices to the $100,000 level could drive VET back up to $0.0500, representing a recovery of approximately 12% from current levels.

23.01.2025
Ontology Is Sliding Towards $0.2000

Ontology (ONT) is down 2.3% this week, trading at $0.2176, in line with the broader crypto market where Bitcoin (BTC) has declined 2.0% to $101,632. While the new U.S. administration has made some strides toward fairer crypto regulation, Donald Trump has remained silent on the highly anticipated issue of adding Bitcoin to U.S. federal reserves.

Market speculation is rampant, with figures like BlackRock CEO Larry Fink suggesting Bitcoin could surge to $700,000 per coin if sovereign wealth funds begin accumulating. Other forecasts predict Bitcoin reaching $250,000 by year-end. While such projections could foster optimism, the lack of decisive action or announcements regarding U.S. crypto reserves is weighing heavily on the market.

For Ontology, the situation remains bearish. Having breached the critical support at $0.2500 last week, the token is now approaching the $0.2000 level. A failure to provide clear evidence or statements about U.S. federal crypto reserve plans could see ONT fall even further, breaching the $0.2000 mark and deepening its losses.

14.01.2025
Merck Becomes Interesting to Be Added to a Portfolio

Merck & Co (MRK) stocks have shown signs of becoming a compelling buy opportunity. Over the past six months, the stock has been in a downtrend, declining 29.8% to $94.50 per share. However, since mid-November, MRK has demonstrated a reversal of momentum, rebounding by 10.0% to reach $104.87 on December 5. Following a brief pullback and consolidation period, the stock has retested the downtrend resistance and appears poised to continue its upward trajectory.

With prices currently positioned to target $110.00, this represents a potential 9-10% upside from the present levels. Setting a stop-loss at $93.50 aligns with a prudent risk management strategy, providing protection against further downside while allowing for upside potential. The recent consolidation phase further supports the case for a breakout, making this an attractive moment to consider initiating or adding to a position in MRK.

Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
Google Diamond for Christmas

Christmas presents have yet to come, by The Fed has already surprised investors by clearly declaring an end to its interest rates hikes cycle in coming months. The S&P 500 index surged 1.2%, Nasdaq 100 added 1.4%. The high-tech behemoth Alphabet stocks are unchanged at $133.60. I see a Diamond pattern on the chart that promise potential rise of 16.0-17.0%. I will open long trade after GOOG stock prices will pass the $140.00 barrier targeting $155.00 per share. The stop-loss could be placed at $129.00.

1948
B
The Federal Reserve Set the Scene for USD Weakness

The difference between two rate path projections delivered by the Federal Reserve in September and December is pretty clear. Just for comparison, there was only a minority consisting of 9 votes in favour of a more cautious stance with two or more rate cuts three month ago. Ultimately, the cap for monetary policy tightening has been built. And now, under condition if the European Central Bank, as well as the Bank of England and the Swiss National Bank would decide to exercise more shyness in exposing themselves as explicit doves, which is seemingly a likely scenario, this contrast could logically lead to the U.S. Dollar weakening in the mid-term. EUR/USD has already got halfway to cover its recent two-week correction from above 1.10 to 1.0720, making one leap to 1.09 area immediately. Another move to its November highs would be inevitable if the European central bankers would be hesitant or too much focused on the inflation agenda, for example. Swiss Franc could partially replace the U.S. Dollar as a safe haven asset in portfolios. Meanwhile, I prefer to buy the Sterling Pound vs the Greenback as soon as GBP/USD break and hold above 1.2650 psychological resistance, as the pair has enough space to test 1.30, potentially giving the best profit/risk ratio among other bets on U.S. Dollar rivals. I am going to place my stop loss orders to 1.2525 for this deal.

3844
Stocks Dipping Amid the Christmas Rally: Pfizer

Shares of this multinational pharmaceutical and biotechnology corporation were very popular among investing crowds during the pandemic, when it developed the first COVID-19 vaccine. Its revenue exceeded $100 billion in 2022, yet later the number slipped to $44.2 billion only for the first nine months of 2023, when the therapy measures dominated over fresh prophylactic spending.

Therefore, the stock entered into a strong adjustment period, from nearly $55 per share in December 2022 to below $28.5 one year later. And it fell by another 7.5% to $26.5 shortly before the trading session on December 13, following the company's own outlook forecasts for 2024. Dr. Albert Bourla, Pfizer CEO said that his company's annual revenue would be supposedly at $60 billion, up or down $1.5 billion, which is well below the Wall Street pool's consensus of $63.1 billion, including approximately $8 billion from COVID-19 products like Comirnaty and Paxlovid and $3.1 billion from Seagen cancer care medicine, as Pfizer is completing the acquisition of this business. Nevertheless, diluted equity per share (EPS) could be within a range of $2.05 to $2.25, big expected failure vs the consensus value of $3.16.

“Pfizer’s product portfolio remains strong. In 2024, ... our remaining portfolio [except COVID-19 related drugs] of combined Pfizer and Seagen products is expected to achieve YoY operational revenue growth in the range of 8% to 10%... In addition, we expect our cost realignment program to deliver savings of at least $4.0 billion... which puts us on a path to potentially regain our pre-pandemic operating margins," Dr. Albert Bourla said struggling to sound more optimistic. Yet, further possible decline in Pfizer stock is probably on the table, so that it is just going to skip the Christmas rally mood in the best case.

2855
Stocks Shining Amid the Christmas Rally: Broadcom

The investment vehicle, which we previously characterized as a kind of safe haven asset for the long-term on September 15, 2022, more than doubled its market value since that time, with only the last three days contributing another 16.2% to the overall result. The last portion of very excited, much stronger upside momentum was related to a fresh Buy rating for Broadcom from the analyst team of Citigroup, as they defined a $1,100 price target, citing a friendly artificial intelligence (AI) environment to offset a partial downturn in other semiconductor segments. Citigroup's recent investigation highlighted the software developer's potential to increase substantially its AI-based sales from nearly $4.0 billion in the financial year of 2023 to over $8.0 billion in the next year.

The share price of Broadcom closed the Wall Street trading session at $1072.28 on December 12, compared to $944.30 before the weekend. High volatility, combined with slightly overbought conditions could give reasons to book some good annual profit if anyone wishes so, yet the horizon still looks clear for nearest months. Broadcom combines the best features from pure-play software platforms, AI chip developers and hardware accelerator offerings, as its chips are supporting chatbots like ChatGPT or Google built Bard or Gemini systems to reply quicker when users make their endless requests.

The technical foundation behind the move became stronger after Broadcom slipped from late November to the first decade of December despite strong 2024 guidance and Q3 2023 earnings, which topped consensus expectations setting new all-time records in both revenue and profit lines. The stock continued its moderate price adjustment within 7% or 8% altogether before and after the report, though the company actually earned $11.06 per share on $9.295 billion in revenue against Wall Street analysts pool estimates, averagely betting on $10.96 per share on $9.28 billion in revenue. Many traders used to consider a somewhat postponed wave of stock price growth as a sign of more healthy developments in trend movements, which is good for the future periods. Semiconductor solutions sales came out at $7.33 billion, up 3% YoY, while infrastructure software added about 7% during the same period to $1.97 billion. Free cash flow came in at $4.72 billion, roughly 51% of revenue. Broadcom also raised its quarterly dividend payment to shareholders by 14% to $5.25 per share, being the thirteenth consecutive increase in annual dividends. Looking to fiscal 2024, many analysts agree with Broadcom's own estimates of the company's revenue to soar above $50 billion, which would mark an increase of 40% from the prior year period, especially as the situation is additionally supported by the recent VMware company's acquisition.

2392
167

Join our community

Share your professional and amateur observations, exchange experiences, anticipate developments

Category
All
Stocks
Crypto
Etf
Commodities
Indices
Currencies
Energies
Metals
Instruments
Author
All
Metadoro
Contributors